Loading...
Efficacy and Safety of Treatment With Ferric Carboxymaltose in Patients With Cirrhosis and Gastrointestinal Bleeding
Background: Patients with liver cirrhosis and gastrointestinal bleeding (GIB) often develop anemia. Ferric carboxymaltose (FCM) is an intravenous (i.v.) iron formulation approved for use in patients with iron deficiency with inadequate response to oral iron therapy or when oral iron cannot be used....
Saved in:
| Published in: | Front Med (Lausanne) |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Frontiers Media S.A.
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7181670/ https://ncbi.nlm.nih.gov/pubmed/32363194 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2020.00128 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|